Paris, June 21, 2021 – Luneau Technology and Optovue Inc have announced the signing of a definitive agreement to merge. The newly merged company will continue to serve eyecare professionals as a major player with innovative product lines and a strong focus on its telehealth solution. The transaction remains subject to additional customary conditions to completion and legal approvals.
Their combined power will allow them to leverage their industry expertise, strengthen their international footprint, and provide customers with game-changing solutions spanning a full product range. Their joint vision is to be the first-choice partner for primary eyecare physicians and significantly optimize access to visual health for patients across the globe.
Dr. Marc Abitbol will preside over the newly merged company, while Peter Wyles will continue his role as CEO of Optovue. Luneau Technology and Optovue will continue to deploy products through their existing channels and will initially focus on the sharing of best practices to fuel the future development and innovation of their core products.
“This is the perfect marriage,” exclaims Dr. Abitbol. “It will benefit us, our clients and patients. Optical Coherence Tomography is the next technology we were looking for, and it fits beautifully into our product offering. By joining forces with Optovue, we’ll be able to offer a significantly improved customer experience with full front- and back-of-the-eye platforms – stronger together.”
Wyles agrees. “This merger really makes sense for both of our companies” he adds. “We are thrilled to work together toward our common vision, while at the same time, significantly optimizing the customer experience. We’re excited about embarking on this exciting new journey.”